John S. Tokarski, Princeton US
John S. Tokarski, Princeton, NJ US
Patent application number | Description | Published |
---|---|---|
20090048244 | PYRROLOTRIAZINE COMPOUNDS AS KINASE INHIBITORS - The present invention provides compounds of formula I | 02-19-2009 |
20100029676 | T315A AND F317I MUTATIONS OF BCR-ABL KINASE DOMAIN - The present invention relates to mutant BCR-ABL kinase proteins, and to diagnostic and therapeutic methods and compositions useful in the management of disorders, for example cancers, involving cells that express such mutant BCR-ABL kinase proteins. | 02-04-2010 |
20110039838 | PYRROLOTRIAZINE COMPOUNDS AS KINASE INHIBITORS - The present invention provides compounds of formula I | 02-17-2011 |
20140005146 | PYRROLOPYRIDAZINE JAK3 INHIBITORS AND THEIR USE FOR THE TREATMENT OF INFLAMMATORY AND AUTOIMMUNE DISEASES | 01-02-2014 |
20140256700 | CARBAZOLE COMPOUNDS USEFUL AS BROMODOMAIN INHIBITORS - The present invention is directed to carbazole compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders. | 09-11-2014 |
20150210697 | IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS - The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents. | 07-30-2015 |
20150299139 | ALKYL AMIDE-SUBSTITUTED PYRIMIDINE COMPOUNDS USEFUL IN THE MODULATION OF IL-12, IL-23 AND/OR IFN ALPHA - Compounds having the following formula (I): or a stereoisomer or pharmaceutically-acceptable salt thereof, where R | 10-22-2015 |
20150299183 | AMIDE-SUBSTITUTED HETEROCYCLIC COMPOUNDS USEFUL AS MODULATORS OF IL-12, IL-23 AND/OR IFN ALPHA RESPONSES - Compounds having the following formula I: or a stereoisomer or pharmaceutically-acceptable salt thereof, where R | 10-22-2015 |